Obesity of children
Conditions
Interventions
Experimental group:Two weeks before all the subjects were observed, they were given face-to-face balanced diet education for about 1 hour each time. The contents are as follows: ? Guidance of dietary
? The importance and basic principles of a balanced diet
? How to make a personalized diet plan according to the principle of balanced diet. During the intervention period of the following three months, online education was conducted once a month in groups
Control group:Two weeks before all the subjects were observed, they were given face-to-face balanced diet education for about 1 hour each time. The contents are as follows: ? Guidance of dietary recor
Sponsors
The Fifth People's Hospital of Shanghai
Eligibility
Sex/Gender
All
Age
6 Years to 9 Years
Inclusion criteria
Inclusion criteria: For obese children aged 6-9 years old who were treated in the pediatric growth and development clinic of our hospital from January 2024 to June 2024, the subjects met the diagnostic criteria for childhood obesity, and the age-specific BMI reference threshold of the "Health Industry Standard of the People's Republic of China (WS/T423-2022)" for children under 7 years old was referred to. Children aged 7-9 years can refer to the age-specific BMI reference cut-off points in the Screening for Overweight and Obesity in School-Age Children and Adolescents.
Exclusion criteria
Exclusion criteria: (1) People with food allergies: gluten, eggs, peanuts, tree nuts, milk allergies; (2) Congenital heart disease, genetic metabolic diseases and other basic diseases and congenital malformations; (3) Brain injury caused by various causes; (4) Patients who can not be taken orally in the whole intestine, and patients with severe gastrointestinal diseases such as digestive ulcer and inflammatory bowel disease; (5) Supplement probiotics or prebiotics; (6) Antibiotics have been used in the past week
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intestinal flora composition and abundance of beneficial bacteria;Blood examination: FBG ALT TC TG HDL-C LDL-C TNF-a IL-6 VitD;Adverse events during the trial and the occurrence of serious adverse events.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical measurement index;Liver fat variable value (CAP); | — |
Countries
China
Contacts
Public ContactFei Wang
The Fifth People's Hospital of Shanghai
Outcome results
None listed